Over the last 180 days, GYRE THERAPEUTICS, INC. insiders sold a net $952.9K of stock across 110 Form 4 purchases and sales, with 0 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-06.
Showing the most recent few. Create a free account to see 105 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| REVENUE | $116.6M | $105.8M | $113.5M | $102.3M |
| GROSS PROFIT | — | $101.9M | $108.8M | $97.5M |
| OPERATING INCOME | $11.5M | $16.2M | $-67.2M | $9.2M |
| NET INCOME | $9.9M | $17.9M | $-85.5M | $4.3M |
| EPS (DILUTED) | 0.02 | 0.05 | -1.41 | 0.03 |
| OPERATING CASH FLOW | $1.0M | $-3.6M | $25.9M | $10.7M |
| CASH | $37.1M | $11.8M | $33.5M | $25.2M |
| DIVIDENDS PAID | — | — | — | $45.0M |
No password to create and no card required. We store your email address and nothing else.